| Obesity paradox in cardiovascular disease: where do we stand? S Carbone, JM Canada, HE Billingsley, MS Siddiqui, A Elagizi, CJ Lavie Vascular health and risk management, 89-100, 2019 | 395 | 2019 |
| Exercise intolerance in patients with heart failure: JACC state-of-the-art review MG Del Buono, R Arena, BA Borlaug, S Carbone, JM Canada, ... Journal of the American College of Cardiology 73 (17), 2209-2225, 2019 | 303 | 2019 |
| Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study) BW Van Tassell, R Arena, G Biondi-Zoccai, JM Canada, C Oddi, ... American journal of Cardiology 113 (2), 321-327, 2014 | 241 | 2014 |
| Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure BW Van Tassell, RA Arena, S Toldo, E Mezzaroma, T Azam, IM Seropian, ... PloS one 7 (3), e33438, 2012 | 220 | 2012 |
| Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial) BW Van Tassell, JM Canada, S Carbone, C Trankle, L Buckley, CO Erdle, ... Circulation: Heart Failure 10 (11), e004373, 2017 | 186 | 2017 |
| Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction A Abbate, CR Trankle, LF Buckley, MJ Lipinski, D Appleton, D Kadariya, ... Journal of the American Heart Association 9 (5), e014941, 2020 | 180 | 2020 |
| IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2 BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ... Circulation: Heart Failure 11 (8), e005036, 2018 | 147 | 2018 |
| Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐HART2) BW Van Tassell, LF Buckley, S Carbone, CR Trankle, JM Canada, ... Clinical cardiology 40 (9), 626-632, 2017 | 116 | 2017 |
| Heart failure with preserved ejection fraction: refocusing on diastole A Abbate, R Arena, N Abouzaki, BW Van Tassell, JM Canada, K Shah, ... International journal of cardiology 179, 430-440, 2015 | 114 | 2015 |
| Dietary fat, sugar consumption, and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction S Carbone, JM Canada, LF Buckley, CR Trankle, HE Billingsley, ... Basic to Translational Science 2 (5), 513-525, 2017 | 98 | 2017 |
| IL-1 blockade reduces inflammation in pulmonary arterial hypertension and right ventricular failure: a single-arm, open-label, phase IB/II pilot study CR Trankle, JM Canada, D Kadariya, R Markley, HM De Chazal, J Pinson, ... American journal of respiratory and critical care medicine 199 (3), 381-384, 2019 | 80 | 2019 |
| Phase 1b, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral nlrp3 inhibitor dapansutrile in subjects with … GF Wohlford, BW Van Tassell, HE Billingsley, D Kadariya, S Carbone, ... Journal of cardiovascular pharmacology 77 (1), 49-60, 2021 | 73 | 2021 |
| Canada JM, Kirkman DL, Garten R, Rodriguez-Miguelez P, Guazzi M, Lavie CJ, Abbate A. Exercise intolerance in patients with heart failure: JACC state-of-the-art review MG Del Buono, R Arena, BA Borlaug, S Carbone J Am Coll Cardiol 73 (17), 2209-2225, 2019 | 67 | 2019 |
| Obesity contributes to exercise intolerance in heart failure with preserved ejection fraction S Carbone, JM Canada, LF Buckley, CR Trankle, DL Dixon, R Buzzetti, ... Journal of the American College of Cardiology 68 (22), 2487-2488, 2016 | 58 | 2016 |
| Usefulness of canakinumab to improve exercise capacity in patients with long-term systolic heart failure and elevated C-reactive protein CR Trankle, JM Canada, L Cei, N Abouzaki, C Oddi-Erdle, D Kadariya, ... The American journal of cardiology 122 (8), 1366-1370, 2018 | 56 | 2018 |
| Low NT‐proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction LF Buckley, JM Canada, MG Del Buono, S Carbone, CR Trankle, ... ESC heart failure 5 (2), 372-378, 2018 | 53 | 2018 |
| Rationale and design of the Virginia Commonwealth University–Anakinra Remodeling Trial‐3 (VCU‐ART3): A randomized, placebo‐controlled, double‐blinded, multicenter study BW Van Tassell, MJ Lipinski, D Appleton, CS Roberts, MC Kontos, ... Clinical cardiology 41 (8), 1004-1008, 2018 | 50 | 2018 |
| Canada LF Buckley, S Carbone, CR Trankle JM, Del Buono, MG, Carbone, S., Trankle, CR, Billingsley, H., Kadariya, D …, 2018 | 47 | 2018 |
| Interleukin-1 blockade in rheumatoid arthritis and heart failure: a missed opportunity? A Abbate, JM Canada, BW Van Tassell, CM Wise, CA Dinarello International journal of cardiology 171 (3), e125-e126, 2014 | 32 | 2014 |
| Exercise blood pressure response during assisted circulatory support: Comparison of the total artifical heart with a left ventricular assist device during rehabilitation HS Kohli, JM Canada, R Arena, DG Tang, MA Peberdy, S Harton, ... The Journal of Heart and Lung Transplantation 30 (11), 1207-1213, 2011 | 32 | 2011 |
